Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001396814-25-000102
Filing Date
2025-08-05
Accepted
2025-08-05 16:07:30
Documents
104
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pcrx-20250630.htm   iXBRL 10-Q 1881126
2 EX-31.1 pcrx-6302025xex311.htm EX-31.1 11606
3 EX-31.2 pcrx-6302025xex312.htm EX-31.2 11581
4 EX-32.1 pcrx-6302025xex321.htm EX-32.1 8074
10 PACIRA BIOSCIENCES LOGO pcrx-20250630_g1.jpg GRAPHIC 82257
11 PRODUCT PIPELINE pcrx-20250630_g2.jpg GRAPHIC 181535
  Complete submission text file 0001396814-25-000102.txt   12083836

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20250630.xsd EX-101.SCH 75703
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcrx-20250630_cal.xml EX-101.CAL 116046
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcrx-20250630_def.xml EX-101.DEF 520606
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20250630_lab.xml EX-101.LAB 963171
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20250630_pre.xml EX-101.PRE 733777
107 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20250630_htm.xml XML 1728371
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005 650-242-8052
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35060 | Film No.: 251184984
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)